Nang Kuang Pharmaceutical Co., Ltd.(TW:1752)
NT$29.900.00 (0.00%)
TW:1752
Nang Kuang Pharmaceutical Co., Ltd. financials statements
NT$29.90
At close:0.00 (0.00%)
Nang Kuang Pharmaceutical Co., Ltd. (1752) Income Statement
Nang Kuang Pharmaceutical Co., Ltd. Income Statement
Last quarter (Q2 2026), Nang Kuang Pharmaceutical Co., Ltd.'s total revenue was NT$538.59M, a decrease of 0.58% from the same quarter last year. In Q2, Nang Kuang Pharmaceutical Co., Ltd.'s net income was NT$51.74M. See Nang Kuang Pharmaceutical Co., Ltd.’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| NT$ 2.16B | NT$ 2.20B | NT$ 2.15B | NT$ 1.94B | NT$ 1.78B | |
| NT$ 768.86M | NT$ 747.79M | NT$ 755.56M | NT$ 694.90M | NT$ 594.47M | |
| NT$ 473.19M | NT$ 440.25M | NT$ 495.65M | NT$ 371.09M | NT$ 338.02M | |
| Depreciation and Amortization | NT$ 183.14M | NT$ 182.96M | NT$ 181.96M | NT$ 176.28M | NT$ 179.75M |
| NT$ 478.81M | NT$ 491.69M | NT$ 402.70M | NT$ 591.75M | NT$ 418.04M | |
| NT$ 295.67M | NT$ 307.55M | NT$ 259.91M | NT$ 417.67M | NT$ 233.76M | |
| NT$ -4.53M | NT$ -4.34M | NT$ -46.23M | NT$ -7.05M | NT$ 1.00M | |
| NT$ 291.14M | NT$ 303.20M | NT$ 213.68M | NT$ 410.63M | NT$ 234.76M | |
| NT$ 243.95M | NT$ 243.41M | NT$ 198.41M | NT$ 352.00M | NT$ 196.11M | |
| Per Share Metrics | |||||
| Basic EPS | NT$ 2.42 | NT$ 2.41 | NT$ 1.96 | NT$ 3.49 | NT$ 1.94 |
| Diluted EPS | NT$ 2.42 | NT$ 2.40 | NT$ 1.96 | NT$ 3.48 | NT$ 1.94 |
| Weighted Average Shares Outstanding | 100.81M | 100.99M | 101.15M | 100.99M | 100.99M |
| Weighted Average Shares Outstanding (Diluted) | 100.81M | 101.25M | 101.15M | 101.23M | 101.23M |
Currency in TWD

